Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Myeloma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 516 active Multiple Myeloma trials
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
Study Type: Observational
Isa-Pom-Dex in Elderly/Frail Subjects With RRMM
Study Type: Interventional Phase 2
Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple Myeloma
Study Type: Interventional Phase 1
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
Study Type: Interventional Phase 2
Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma
Study Type: Interventional Phase 1
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Study Type: Interventional Phase 3
CART-38 in Adult AML and MM Patients
Study Type: Interventional Phase 1
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
Study Type: Observational
There are 516 active Multiple Myeloma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now